Mark L. Hartman

10.1k citations
103 papers · 7.3k indexed · 5 hit papers · h-index 46
Topics
Growth Hormone and Insulin-like Growth Factors (48 papers)Pituitary Gland Disorders and Treatments (18 papers)Diet and metabolism studies (17 papers)

In The Last Decade

Mark L. Hartman

98 papers receiving 7.0k citations

Hit Papers

Triple–Hormone-Receptor Agonist Retatrutide...202020262022202420232024202020232024100200300400500

Peers

Mark L. Hartman
Comparison fields: 5 of 136
  • Endocrinology, Diabetes and Metabolism 4.8k
  • Physiology 2.4k
  • Endocrine and Autonomic Systems 1.3k
  • Molecular Biology 1.0k
  • Epidemiology 1.0k
Replace Fausto Santeusanio with:
Fausto Santeusanio Italy
Andrea Fabbri Italy
Martin Bidlingmaier Germany
Michael C. Riddell Canada
Erik Endert Netherlands
William S. Evans United States
Anton Luger Austria
Pierpaolo De Feo Italy
Peter Y. Liu United States
Randall J. Urban United States
Mark L. Hartman relative to Fausto Santeusanio Italy Fausto Santeusanio's profile →
Citations per field
00.5×10×12.9×
Fausto Santeusanio · 1×
Citations per year

Countries citing papers authored by Mark L. Hartman

Since Specialization
Citations

This map shows the geographic impact of Mark L. Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Hartman more than expected).

Fields of papers citing papers by Mark L. Hartman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Hartman. The network helps show where Mark L. Hartman may publish in the future.

Co-authorship network of co-authors of Mark L. Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Hartman. A scholar is included among the top collaborators of Mark L. Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Hartman. Mark L. Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 18
5
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosisbreakdown →
353
6 65
7 40
8 239
9 137
10 159
11 2
12 186
13 20
14 17
15 45
16 117
17 154
18 80
19 62
20 108

About Mark L. Hartman

Mark L. Hartman is a scholar working on Endocrinology, Diabetes and Metabolism, Endocrine and Autonomic Systems and Physiology, having authored 103 papers that have together received 7.3k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (48 papers), Pituitary Gland Disorders and Treatments (18 papers) and Diet and metabolism studies (17 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.8k citations), Endocrine and Autonomic Systems (1.3k citations) and Physiology (2.4k citations). Mark L. Hartman has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Michael O. Thorner, Johannes D. Veldhuis, Arthur Weltman, Judy Y. Weltman, Axel Haupt, Suzan S. Pezzoli, Michael L. Johnson, Jill A. Kanaley, Jody L. Clasey and Yu Du. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026